Inflammatory Cell Adhesion Molecules in Ischemic Cerebrovascular Disease

  • C.J.M. Frijns
    From the Department of Neurology, University Medical Center Utrecht, Utrecht, Netherlands.
  • L.J. Kappelle
    From the Department of Neurology, University Medical Center Utrecht, Utrecht, Netherlands.

この論文をさがす

抄録

<jats:p><jats:bold><jats:italic><jats:bold><jats:italic>Background</jats:italic></jats:bold>—</jats:italic></jats:bold>In this review we discuss the role of inflammatory cell adhesion molecules (CAMs) in ischemic stroke and in delayed cerebral ischemia after subarachnoid hemorrhage. Vascular endothelial cells and leukocytes express several inflammatory adhesion receptors, the most important of which are the selectins, immunoglobulin gene superfamily CAMs, and β2 integrins. They mediate the transmigration process of leukocytes to the abluminal side of the endothelium.</jats:p><jats:p><jats:bold><jats:italic><jats:bold><jats:italic>Summary of Review</jats:italic></jats:bold>—</jats:italic></jats:bold>There is ample evidence from animal models of middle cerebral artery occlusion that expression of CAMs is associated with cerebral infarct size. Absence of CAMs in knockout animals resulted in reduced infarct size. When middle cerebral artery occlusion in experimental stroke was followed by reperfusion, administration of anti-CAM antibodies decreased infarct size. Thus far, anti-CAM treatment has not been successful in patients with ischemic stroke. Inflammatory CAM may also play a role in the pathogenesis of delayed cerebral ischemia after subarachnoid hemorrhage. In animal models, increased expression of CAMs has been observed in vasospastic arteries. Increased concentrations of CAMs have also been found in cerebrospinal fluid of patients with subarachnoid hemorrhage.</jats:p><jats:p><jats:bold><jats:italic><jats:bold><jats:italic>Conclusions</jats:italic></jats:bold>—</jats:italic></jats:bold>Further research on the role of inflammatory CAMs in the pathogenesis of ischemic cerebrovascular disorders should lead to new diagnostic and therapeutic strategies.</jats:p>

収録刊行物

  • Stroke

    Stroke 33 (8), 2115-2122, 2002-08

    Ovid Technologies (Wolters Kluwer Health)

被引用文献 (5)*注記

もっと見る

詳細情報 詳細情報について

問題の指摘

ページトップへ